Carbon monoxide diffusion capacity is decreased in all, except:
**Core Concept**
Carbon monoxide diffusion capacity (DLCO) measures the ability of the lungs to transfer gases from the inhaled air to the blood. It is a critical parameter in assessing lung function, especially in patients with interstitial lung diseases or chronic obstructive pulmonary disease (COPD). The DLCO is influenced by the surface area of the alveoli, the thickness of the alveolar-capillary membrane, and the hemoglobin concentration in the blood.
**Why the Correct Answer is Right**
The correct answer is related to the factors that affect DLCO. A decrease in DLCO can be caused by conditions that damage the alveoli or increase the thickness of the alveolar-capillary membrane. Conditions such as interstitial lung diseases (e.g., pulmonary fibrosis), COPD, and pulmonary edema can all lead to a decrease in DLCO. However, conditions that increase hemoglobin concentration can actually increase DLCO, as there are more binding sites for carbon monoxide.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option would typically decrease DLCO, as conditions that damage the alveoli or increase the thickness of the alveolar-capillary membrane would lead to a decrease in gas transfer.
* **Option B:** This option would also decrease DLCO, as conditions that damage the alveoli or increase the thickness of the alveolar-capillary membrane would lead to a decrease in gas transfer.
* **Option D:** This option would decrease DLCO, as conditions that damage the alveoli or increase the thickness of the alveolar-capillary membrane would lead to a decrease in gas transfer.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that conditions that increase hemoglobin concentration, such as polycythemia vera or carbon monoxide poisoning, can increase DLCO, whereas conditions that damage the alveoli or increase the thickness of the alveolar-capillary membrane can decrease DLCO.
**Correct Answer: A. Interstitial lung disease.**